drugset / Trial / NCT00771745

Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients

NCT00771745

RandomizedParallel-groupOpen-labelPrevention

Summary

To determine how safe and effective giving Thymoglobulin before transplantation to patients who are going to be receiving kidney transplants.

Timeline

Start
2008-09
Primary completion
2010-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Thymoglobulin Protein / enzyme biologic 1.5 mg/kg
Comparator Thymoglobulin Protein / enzyme biologic 3 mg/kg

Indications